Expansion of Typical Values for Paediatric Patients in Ireland and Comparison with Published DRLs - Experiences of a

Andrew Lyons1, Ali Mohammed Ali2, Andrew England1

  • 1Discipline of Medical Imaging & Radiation Therapy, University College Cork, Cork, Ireland.

Insights

This study established weight-based typical values (TVs) for paediatric radiography, finding they correlate with patient weight and exam type. Variations in radiation dose metrics were observed between X-ray rooms, highlighting the need for weight-based diagnostic reference levels (DRLs).

Area of Science:

  • Medical Imaging
  • Radiology
  • Radiation Protection

Background:

  • Ionising radiation exposure necessitates the establishment of typical values (TVs) and diagnostic reference levels (DRLs) to maintain radiation doses 'as low as reasonably practicable'.
  • Paediatric radiation dose metrics should be size-dependent rather than age-dependent for accurate risk management.
  • Standardised radiation dose metrics are crucial for comparative analysis in diagnostic imaging.

Purpose of the Study:

  • To establish and compare paediatric typical values (TVs) for chest, abdomen, and pelvis radiography.
  • To investigate the correlation between patient weight and radiation dose metrics in paediatric patients.
  • To identify variations in radiation dose metrics across different X-ray rooms for paediatric examinations.

Main Methods:

  • Retrospective acquisition of Kerma-area product (KAP) values from 407 paediatric X-ray examinations.
  • Categorisation of paediatric patients into weight-based groupings (5 to <15 kg, 15 to <30 kg, 30 to <50 kg, 50 to 80 kg).
  • Stratification of data by examination type (chest, abdomen, pelvis) and X-ray room, followed by analysis using Microsoft Excel.

Main Results:

  • Established paediatric TVs for chest, abdomen, and pelvis radiography across defined weight categories.
  • Demonstrated a clear trend of increasing TVs with increasing patient weight for all examined radiographic procedures.
  • Observed significant variations in TVs between different X-ray rooms, ranging from -60% to 119% for chest, -50% to 103% for abdomen, and -14% to 24% for pelvis.

Conclusions:

  • Paediatric TVs for radiography align with established trends related to patient weight and examination type.
  • Significant inter-room variability in radiation dose metrics necessitates further investigation.
  • Weight-based TVs/DRLs are recommended for paediatric settings due to the imperfect correlation between age and size.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...